At close: December 13 at 4:00:02 PM EST
After hours: 7:58:52 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-263,992.00
-235,046.00
-316,219.00
-635,639.00
-470,351.00
Investing Cash Flow
5,218.00
154,950.00
250,453.00
562,557.00
-84,345.00
Financing Cash Flow
159,057.00
196,248.00
17,519.00
-93,954.00
546,715.00
End Cash Position
118,652.00
274,597.00
158,445.00
206,692.00
373,728.00
Income Tax Paid Supplemental Data
--
42.00
253.00
617.00
361.00
Capital Expenditure
-7,328.00
-9,057.00
-13,208.00
-23,003.00
-28,986.00
Issuance of Capital Stock
118,126.00
248,198.00
54,237.00
74,975.00
541,536.00
Repayment of Debt
-83,644.00
-54,367.00
-36,734.00
--
--
Free Cash Flow
-271,320.00
-244,103.00
-329,427.00
-658,642.00
-499,337.00
12/31/2020 - 6/19/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TSVT 2seventy bio, Inc.
3.2700
-2.10%
EDIT Editas Medicine, Inc.
1.4400
-23.81%
LXRX Lexicon Pharmaceuticals, Inc.
0.8103
-1.45%
IBRX ImmunityBio, Inc.
2.8700
-5.59%
QURE uniQure N.V.
15.40
+2.26%
NTLA Intellia Therapeutics, Inc.
12.90
-4.87%
BEAM Beam Therapeutics Inc.
27.93
-0.46%
CMRX Chimerix, Inc.
2.9500
+0.34%
MGX Metagenomi, Inc.
3.2400
-16.06%
CRDF Cardiff Oncology, Inc.
3.9200
+19.88%